Hasil Pencarian - Christophe Massard

Perbaiki Hasil
  1. 1
    Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer

    Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer oleh Matthieu Delaye, Adrien Rousseau, Mélanie Try, Christophe Massard, Luca Campedel, Marc Hilmi, Corinne Bagnis

    Diterbitkan 2023-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Case Report: Expanding the tumour spectrum associated with the Birt-Hogg-Dubé cancer susceptibility syndrome [v1; ref status: indexed, http://f1000r.es/3h3]

    Case Report: Expanding the tumour spectrum associated with the Birt-Hogg-Dubé cancer susceptibility syndrome [v1; ref status: indexed, http://f1000r.es/3h3] oleh Patrick R. Benusiglio, Sophie Gad, Christophe Massard, Edith Carton, Elisabeth Longchampt, Tiffany Faudot, Jérôme Lamoril, Sophie Ferlicot

    Diterbitkan 2014-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Long-term complete remission with ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients

    Long-term complete remission with ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients oleh Luc Cabel, Elika Loir, Gwenaelle Gravis, Pernelle Lavaud, Christophe Massard, Laurence Albiges, Giulia Baciarello, Yohann Loriot, Karim Fizazi

    Diterbitkan 2017-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Therapeutic potential of the human endogenous retroviral envelope protein HEMO: a pan‐cancer analysis

    Therapeutic potential of the human endogenous retroviral envelope protein HEMO: a pan‐cancer analysis oleh Amélie Kasperek, Anthony Béguin, Olivia Bawa, Kévin De Azevedo, Bastien Job, Christophe Massard, Jean‐Yves Scoazec, Thierry Heidmann, Odile Heidmann

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials.

    A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials. oleh Emmanuelle Kempf, Nathalie Lemoine, Gabrielle Tergemina-Clain, Anthony Turpin, Sophie Postel-Vinay, Emilie Lanoy, Jean-Charles Soria, Christophe Massard, Antoine Hollebecque

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    MET Receptor Amplification Drives Resistance to Anti-EGFR Therapies

    MET Receptor Amplification Drives Resistance to Anti-EGFR Therapies oleh Patricia Martin Romano, Eduardo Castanon, Antoine Hollebecque, Ludovic Lacroix, Nathalie Auger, Eric Angevin, Lambros Tselikas, Sami Ammari, Jean-Charles Soria, Christophe Massard

    Diterbitkan 2019-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Meta-analysis and Critical Review: Association Between Radio-induced Lymphopenia and Overall Survival in Solid Cancers

    Meta-analysis and Critical Review: Association Between Radio-induced Lymphopenia and Overall Survival in Solid Cancers oleh Yasmine El Houat, MD, Christophe Massard, MD, PhD, Veronique Quillien, MD, Renaud de Crevoisier, MD, PhD, Joël Castelli, MD, PhD

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    391 A first-in-human study of intratumoral SAR441000, an mRNA mixture encoding IL-12sc, interferon alpha2b, GM-CSF and IL-15sushi as monotherapy and in combination with cemiplimab in advanced solid tumors

    391 A first-in-human study of intratumoral SAR441000, an mRNA mixture encoding IL-12sc, interferon alpha2b, GM-CSF and IL-15sushi as monotherapy and in combination with cemiplimab... oleh Evelyna Derhovanessian, Nicolas Acquavella, Christophe Massard, Carmen Loquai, Jochen Utikal, Jean-Francois Baurain, Oliver Bechter, Marie-Laure Ozoux, Rahul Marpadga, Esteban-Rodrigo Imedio

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence

    Limits of radiomic-based entropy as a surrogate of tumor heterogeneity: ROI-area, acquisition protocol and tissue site exert substantial influence oleh Laurent Dercle, Samy Ammari, Mathilde Bateson, Paul Blanc Durand, Eva Haspinger, Christophe Massard, Cyril Jaudet, Andrea Varga, Eric Deutsch, Jean-Charles Soria, Charles Ferté

    Diterbitkan 2017-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Fluorescent Gold Nanoparticles in Suspension as an Efficient Theranostic Agent for Highly Radio-Resistant Cancer Cells

    Fluorescent Gold Nanoparticles in Suspension as an Efficient Theranostic Agent for Highly Radio-Resistant Cancer Cells oleh Sarah Vogel, Alice O’Keefe, Léa Seban, Michael Valceski, Elette Engels, Abass Khochaiche, Carolyn Hollis, Michael Lerch, Stéphanie Corde, Christophe Massard, Komla Oscar Awitor, Moeava Tehei

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Online Public Interest in Urological Cancers During the COVID-19 Pandemic: What Can “Dr. Google” Teach Us?

    Online Public Interest in Urological Cancers During the COVID-19 Pandemic: What Can “Dr. Google” Teach Us? oleh Zine-Eddine Khene, Sonia Guérin, Fares Khene, Benjamin Pradère, Mathieu Roumiguié, Romain Mathieu, Géraldine Pignot, Christophe Massard, Yann Neuzillet, Guillaume Ploussard, Pierre Bigot, Alexandre De la taille, Morgan Rouprêt, Karim Bensalah

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA

    Molecular profiling of biliary tract cancers reveals distinct genomic landscapes between circulating and tissue tumor DNA oleh Clémence Astier, Carine Ngo, Léo Colmet-Daage, Virginie Marty, Olivia Bawa, Claudio Nicotra, Maud Ngo-Camus, Antoine Italiano, Christophe Massard, Jean-Yves Scoazec, Cristina Smolenschi, Michel Ducreux, Antoine Hollebecque, Sophie Postel-Vinay

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types

    Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types oleh Patricia Martin‐Romano, Eduardo Castanon, Samy Ammari, Stéphane Champiat, Antoine Hollebecque, Sophie Postel‐Vinay, Capucine Baldini, Andrea Varga, Jean Marie Michot, Perrine Vuagnat, Aurélien Marabelle, Jean‐Charles Soria, Charles Ferté, Christophe Massard

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic

    Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic oleh Anna Patrikidou, Pierre Maroun, Jean-Jacques Patard, Hervé Baumert, Laurence Albiges, Christophe Massard, Yohann Loriot, Bernard Escudier, Mario Di Palma, Julia Arfi-Rouche, Laurence Rocher, Zahira Merabet, Alberto Bossi, Karim Fizazi, Pierre Blanchard

    Diterbitkan 2018-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma

    Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B-cell lymphoma oleh Cyril Quivoron, Anthony Tarabay, Jean-Marie Michot, Arnaud Pagès, Hélène Lecourt, Anne Aupérin, Alina Danu, Julien Lazarovici, Julien Rossignol, David Ghez, Peggy Dartigues, Véronique Vergé, Christophe Massard, Valérie Camara-Clayette, Vincent Ribrag, Clémentine Sarkozy

    Diterbitkan 2022-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?

    Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker? oleh Patricia Martin-Romano, Julien Adam, Jean-Yves Scoazec, Sébastien Gouy, Antonin Levy, Capucine Baldini, Stéphane Champiat, Jean-Charles Soria, Jean-Charles Soria, Jean-Charles Soria, Christophe Massard, Aurélien Marabelle, Eric Deutsch, Eric Deutsch, Eric Deutsch, Antoine Hollebecque

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Vanucizumab mode of action: Serial biomarkers in plasma, tumor, and skin-wound-healing biopsies

    Vanucizumab mode of action: Serial biomarkers in plasma, tumor, and skin-wound-healing biopsies oleh Florian Heil, Galina Babitzki, Alice Julien-Laferriere, Chia-Huey Ooi, Manuel Hidalgo, Christophe Massard, Maria Martinez-Garcia, Christophe Le Tourneau, Mark Kockx, Peter Gerber, Simona Rossomanno, Oliver Krieter, Angelika Lahr, Norbert Wild, Suzana Vega Harring, Katharina Lechner

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    287 Safety and antitumor activity of indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor KHK2455 in combination with anti-CCR4 monoclonal antibody mogamulizumab in patients with advanced solid tumors

    287 Safety and antitumor activity of indoleamine 2,3-dioxygenase 1 (IDO-1) inhibitor KHK2455 in combination with anti-CCR4 monoclonal antibody mogamulizumab in patients with advanc... oleh Yi Liu, Capucine Baldini, Jameel Muzaffar, David Hong, Olivier Rixe, Christophe Massard, Timothy Yap, Solmaz Sahebjam, Ursa Brown-Glaberman, Andreea Varga, Sergey Efuni, Barbara Kapelan, Eniola Ogunmefun, Tomonori Tayama, Henry Zhao, Denis Healy, Robert Latek, Daisuke Nakashima, Emrullah Yilmaz

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Prognostic value of tumor immune biomarkers in biopsies from patients with refractory solid cancers

    Prognostic value of tumor immune biomarkers in biopsies from patients with refractory solid cancers oleh Tiphaine Lambert, Cedric Pobel, Léo Colmet-Daage, Amélie Bigorgne, Brice RaubyY, Nicolas Sanchez-Escobar Aladro, Lucile Ter-MinassianN, Marie Kerisit, Aurélien Marabelle, Benjamin Besse, Antoine Hollebecque, Stéphane Champiat, Christophe Massard, Daphné Morel, Loic Velringue, Jean-Yves Scoazec

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    378 Efficacy, safety and ancillary analyses of pembrolizumab in combination with nintedanib for the treatment of patients with relapsed advanced mesothelioma

    378 Efficacy, safety and ancillary analyses of pembrolizumab in combination with nintedanib for the treatment of patients with relapsed advanced mesothelioma oleh Capucine Baldini, Francois-Xavier Danlos, Aurélien Marabelle, Jean-Charles Soria, Christophe Massard, Lydie Cassard, Julien Adam, David Planchard, Andreea Varga, Gérard Zalcman, Nathalie Chaput-Gras, Matthieu Texier, Severine Mouraud, Bastien Job, Diane Letourneur, Delphine Bredel, Salim Laghouati, Nathalie Droin, Aurelien Parpaleix, Audrey Rabeau

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: